This article is based on the ECTRIMS lecture given at the 25th ECTRIMS meeting which was held in Düsseldorf, Germany, from 9 to 12 September 2009. Five challenges have been identified: (1) safeguarding the principles of medical ethics; (2) optimizing the risk/benefit ratio; (3) bridging the gap between multiple sclerosis and experimental autoimmune encephalitis; (4) promoting neuroprotection and repair; and (5) tailoring multiple sclerosis therapy to the individual patient. Each of these challenges will be discussed and placed in the context of current research into the pathogenesis and treatment of multiple sclerosis
Abstract: Multiple sclerosis (MS) is an autoimmune disorder of the central nervous system (CNS) and ...
Multiple sclerosis is a major cause of neurological disability, which accrues predominantly during p...
Multiple sclerosis (MS) offers important challenges to understanding its complex genetics and molecu...
This article is based on the ECTRIMS lecture given at the 25th ECTRIMS meeting which was held in Düs...
This article is based on the ECTRIMS lecture given at the 25(th) ECTRIMS meeting which was held in D...
Multiple sclerosis (MS) is the commonest non-traumatic disabling disease to affect young adults. The...
PURPOSE OF REVIEW Despite dramatic advances in the treatment of people with multiple sclerosis over ...
Multiple sclerosis (MS) is an immune system demyelinating and neurodegenerative disease of the centr...
Background: Multiple sclerosis (MS) is a chronic and autoimmune disease of the central nervous syste...
For the past four decades, multiple sclerosis (MS) has been a focus for clinical trial development a...
Every 5 minutes, someone somewhere in the world is diagnosed with an inflammatory, demyelinating, ne...
preventing the future: actively managing multiple sclerosis Michael Hutchinson Relapsing-remitting m...
Multiple sclerosis (MS) is the most frequent inflammatory and demyelinating disease of the Central N...
Conferences traditionally play an important role in the ongoing medical education of healthcare prof...
Introduction. There are not many conditions in which the last few decades have brought such a major ...
Abstract: Multiple sclerosis (MS) is an autoimmune disorder of the central nervous system (CNS) and ...
Multiple sclerosis is a major cause of neurological disability, which accrues predominantly during p...
Multiple sclerosis (MS) offers important challenges to understanding its complex genetics and molecu...
This article is based on the ECTRIMS lecture given at the 25th ECTRIMS meeting which was held in Düs...
This article is based on the ECTRIMS lecture given at the 25(th) ECTRIMS meeting which was held in D...
Multiple sclerosis (MS) is the commonest non-traumatic disabling disease to affect young adults. The...
PURPOSE OF REVIEW Despite dramatic advances in the treatment of people with multiple sclerosis over ...
Multiple sclerosis (MS) is an immune system demyelinating and neurodegenerative disease of the centr...
Background: Multiple sclerosis (MS) is a chronic and autoimmune disease of the central nervous syste...
For the past four decades, multiple sclerosis (MS) has been a focus for clinical trial development a...
Every 5 minutes, someone somewhere in the world is diagnosed with an inflammatory, demyelinating, ne...
preventing the future: actively managing multiple sclerosis Michael Hutchinson Relapsing-remitting m...
Multiple sclerosis (MS) is the most frequent inflammatory and demyelinating disease of the Central N...
Conferences traditionally play an important role in the ongoing medical education of healthcare prof...
Introduction. There are not many conditions in which the last few decades have brought such a major ...
Abstract: Multiple sclerosis (MS) is an autoimmune disorder of the central nervous system (CNS) and ...
Multiple sclerosis is a major cause of neurological disability, which accrues predominantly during p...
Multiple sclerosis (MS) offers important challenges to understanding its complex genetics and molecu...